These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19706181)

  • 1. Possible role of glial cells in the onset and progression of Lyme neuroborreliosis.
    Ramesh G; Borda JT; Gill A; Ribka EP; Morici LA; Mottram P; Martin DS; Jacobs MB; Didier PJ; Philipp MT
    J Neuroinflammation; 2009 Aug; 6():23. PubMed ID: 19706181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Lyme disease spirochete Borrelia burgdorferi induces inflammation and apoptosis in cells from dorsal root ganglia.
    Ramesh G; Santana-Gould L; Inglis FM; England JD; Philipp MT
    J Neuroinflammation; 2013 Jul; 10():88. PubMed ID: 23866773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation in the pathogenesis of lyme neuroborreliosis.
    Ramesh G; Didier PJ; England JD; Santana-Gould L; Doyle-Meyers LA; Martin DS; Jacobs MB; Philipp MT
    Am J Pathol; 2015 May; 185(5):1344-60. PubMed ID: 25892509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of dexamethasone and meloxicam on Borrelia burgdorferi-induced inflammation in neuronal cultures of dorsal root ganglia and myelinating cells of the peripheral nervous system.
    Ramesh G; Meisner OC; Philipp MT
    J Neuroinflammation; 2015 Dec; 12():240. PubMed ID: 26700298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis.
    Ramesh G; Borda JT; Dufour J; Kaushal D; Ramamoorthy R; Lackner AA; Philipp MT
    Am J Pathol; 2008 Nov; 173(5):1415-27. PubMed ID: 18832582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dexamethasone and meloxicam on Borrelia burgdorferi-induced inflammation in glial and neuronal cells of the central nervous system.
    Ramesh G; Martinez AN; Martin DS; Philipp MT
    J Neuroinflammation; 2017 Feb; 14(1):28. PubMed ID: 28153013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aprepitant limits in vivo neuroinflammatory responses in a rhesus model of Lyme neuroborreliosis.
    Martinez AN; Burmeister AR; Ramesh G; Doyle-Meyers L; Marriott I; Philipp MT
    J Neuroinflammation; 2017 Feb; 14(1):37. PubMed ID: 28202084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonist of the neurokinin-1 receptor curbs neuroinflammation in ex vivo and in vitro models of Lyme neuroborreliosis.
    Martinez AN; Ramesh G; Jacobs MB; Philipp MT
    J Neuroinflammation; 2015 Dec; 12():243. PubMed ID: 26714480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathogenicity of non-viable Borrelia burgdorferi ex vivo.
    Parthasarathy G; Gadila SKG
    Sci Rep; 2022 Jan; 12(1):688. PubMed ID: 35027599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
    Ljøstad U; Mygland A
    J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal cord involvement in the nonhuman primate model of Lyme disease.
    Bai Y; Narayan K; Dail D; Sondey M; Hodzic E; Barthold SW; Pachner AR; Cadavid D
    Lab Invest; 2004 Feb; 84(2):160-72. PubMed ID: 14688796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors: insights into their possible role in the pathogenesis of lyme neuroborreliosis.
    Bernardino AL; Myers TA; Alvarez X; Hasegawa A; Philipp MT
    Infect Immun; 2008 Oct; 76(10):4385-95. PubMed ID: 18694963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminating between Lyme neuroborreliosis and other central nervous system infections by use of biomarkers CXCL13 and IL-6.
    Leth TA; Dessau RB; Møller JK
    Ticks Tick Borne Dis; 2022 Sep; 13(5):101984. PubMed ID: 35709639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglia are mediators of Borrelia burgdorferi-induced apoptosis in SH-SY5Y neuronal cells.
    Myers TA; Kaushal D; Philipp MT
    PLoS Pathog; 2009 Nov; 5(11):e1000659. PubMed ID: 19911057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children.
    Barstad B; Tveitnes D; Noraas S; Selvik Ask I; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
    Pediatr Infect Dis J; 2017 Dec; 36(12):e286-e292. PubMed ID: 28661964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible role for inflammation in mediating apoptosis of oligodendrocytes as induced by the Lyme disease spirochete Borrelia burgdorferi.
    Ramesh G; Benge S; Pahar B; Philipp MT
    J Neuroinflammation; 2012 Apr; 9():72. PubMed ID: 22524232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nervous system Lyme disease.
    Halperin JJ
    J R Coll Physicians Edinb; 2010 Sep; 40(3):248-55. PubMed ID: 21127770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of neuroborreliosis--lessons from a monkey model.
    Pachner AR; Schaefer H; Amemiya K; Cadavid D; Zhang WF; Reddy K; O'Neill T
    Wien Klin Wochenschr; 1998 Dec; 110(24):870-3. PubMed ID: 10048168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lyme Neuroborreliosis in Children: Etiology and Comparison of Clinical Findings of Lyme Neuroborreliosis Caused by Borrelia garinii and Borrelia afzelii.
    Rožič M; Lah LL; Ružić-Sabljić E; Kastrin A; Arnež M
    Pediatr Infect Dis J; 2019 Nov; 38(11):e279-e284. PubMed ID: 31306350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.
    Hytönen J; Kortela E; Waris M; Puustinen J; Salo J; Oksi J
    J Neuroinflammation; 2014 Jun; 11():103. PubMed ID: 24920219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.